ARTICLE
ocl.2011.0420
Auteur(s) : Bernadette Delplanque1 bernadette.delplanque@u-psud.fr,
Qin Du2,4, Pascale Leruyet3, Genevieve Agnani, Nicole Pages1, Daniel Gripois1, Hassina ould-Hamouda1, Pierre Carayon4, Jean-Charles Martin2
1 UMR 8195 CNPS « Centre de Neurosciences
Paris-Sud »,
NMPA « Neuroendocrinologie Moléculaire de la Prise
Alimentaire »,
Université Paris-Sud XI,
Orsay,
F- 91405 France
2 UMR1260,
Plateau BioMeT,
Marseille,
F-13385 France;
Univ Aix-Marseille,
Faculté de Médecine Timone,
Marseille,
F-13385 France
3 LACTALIS,
R&D,
Retiers,
F-35240 France
4 Hopital de La Timone,
Service of Biochemistry and Molecular Biology,
Marseille,
F-13005 France
Docosahexaenoic acid (DHA;22:6n-3) and arachidonic acid
(AA;20:4n-6) are highly concentrated in mammalian nervous and
visual systems (Innis, 2007). There is an increased demand for n-3
long-chain polyunsaturated fatty acids (LC-PUFA), particularly DHA,
to support optimal visual and cognitive development in infants
during fetal life and newborn nursing (Simopoulos, 1991; Innis
et al., 2001; Hoffman et al., 2000). Linoleic acid
(LA;18:2n-6) and alpha-linolenic acid (ALA;18:3n-3) are the
precursors of long-chain n-6 and n-3 fatty acids, respectively.
Although they can be synthesized from their respective precursor
fatty acids (Mohrhauer and Holman, 1963), and, although it has been
shown in rats that supplementation of mothers with ALA or DHA leads
to the same LC-PUFA accretion in maternal, fetal and newborn brains
(Valenzuela et al., 2004; Childs et al., 2010b;
Childs et al., 2011), synthesis (especially DHA synthesis)
could be insufficient to cover growth needs (Poumes-Ballihaut et
al., 2001; Bowen and Clandinin, 2005; Plourde and Cunnane,
2007). Therefore, it may be necessary to increase the dietary
intake of DHA and/or increase the synthetic capacity for
metabolizing ALA to DHA in mothers and newborns (Guesnet and
Alessandri, 2010).
Infant formulas were gradually replacing mother's milk for more
than 50 years and, at least in Europe are usually prepared with
vegetable oils. The compositions of these formulas are controlled
in terms of fat for most fatty acids and especially essential fatty
acids (European Economical Community rules, 2008; Alessandri et
al., 1996). Furthermore, in an attempt to mimic the composition
of mother's milk, long chains n-3 and n-6 fatty acids (DHA and ARA)
could be added (Alessandri et al., 1996; Guesnet and
Alessandri, 2010).
Throughout the ages, infant formulas have been prepared with
dairy fat, which, to some extent, is less different from breast
milk for some components that are not present in vegetable fat
formulas (i.e., cholesterol and short-chain FA) (Radbill, 1981).
For example, the short- or medium-chain fatty acids in milk fat are
more efficiently absorbed and might be beneficial for health (Bach
and Babayan, 1982). Some studies reported the beneficial impact of
dairy products on the bioconversion of ALA in humans or animal
studies (Dabadie et al., 2005; Rioux et al., 2011;
Legrand et al., 2010). However, the use of dairy fat for
infant formulas is still a matter of debate in various countries
(Stevens et al., 2009).
Breast feeding is promoted all over the world as the gold
standard, at least for the two to six first months. However the
quality of Infant formulas for the following months is still
important, and the use of dairy fat during this period could be of
interest.
In an attempt to validate the potential replacement of vegetable
fats with dairy fat in infant formulas, we used the rat as a
nutritional model, since many studies aiming determinating of the
needs of the human brain are based on this model since more than 30
years. This animal was used in our study to compare the effects on
brain fatty acids (specifically DHA) of dietary blends based on
dairy fat instead of palm oil, which provide the same quantities of
essential fatty acids. The levels of ALA and LA in these
experimental diets followed the recommended and commonly used
values in most commercial vegetable fat formulas. For this purpose,
sunflower and rapeseed oils were added to maintain the levels of
ALA (1.5%) and LA (16%) and the n-6/n-3 ratio within the
recommended values of 9 to 10.
Because human milk contains DHA (0.2-0.4%) and ARA (0.4-0.8%),
it has been proposed that formulas that replace breast-feeding
should be supplemented with these long-chain n-3 fatty acids
(Guesnet and Alessandri, 2010). Therefore, we also compared the
previous dairy and palm blends to a classical ALA-enriched (1.5%)
palm blend enriched with DHA and ARA levels similar to those used
in infant formulas (0.12% and 0.40% of fatty acids).
In the present work, we compared the effects of ALA enriched
dairy-fat-blend and palm-ALA regular blends (with or without
supplementation with long-chain n-3) on the restoration of the
fatty acid profiles of brains from ALA-deficient post-weaning
rats.
For this purpose we used a model of rat brain restoration of n-3
fatty acids by using different blends of lipids in the first
generation of post-weaning rats (males and females) deficient in
n-3, born from ALA-poor dams (Du et al., 2011). ALA
deficiency over both gestation and lactation in the dams was
achieved by feeding a palm-oil-blend-based diet (0.4% ALA), and the
rat pups were then switched at weaning to either a palm-oil-blend
diet or to a dairy-fat diet supplemented with sunflower and
rapeseed oils to maintain 16% LA and 1.5% ALA for 6 weeks
(table 1).
Table 1 Fatty acid composition of the diets. Palm, Palm +
DHA and dairy fat were blended with rapeseed and sunflower oils to
maintain an ALA level of 1.5% of total fat.
| FA |
Palm ALA 1,5% |
Palm ALA 1,5% + DHA |
Dairy fat ALA 1,5% |
| Myristic |
0,82 |
0,82 |
7,48 |
| Palmitic |
36,15 |
36,15 |
19,85 |
| Stearic |
4,12 |
4,12 |
9,64 |
| Oleic |
38,44 |
38,44 |
26,62 |
| 18:2n-6 |
15,98 |
15,98 |
13,88 |
| 18:3n-3 |
1,56 |
1,56 |
1,53 |
| n-6/n-3 |
10,27 |
10,27 |
9,09 |
| SFA |
42 |
42 |
41 |
| DHA added |
0 |
0,12 |
0 |
| Short and medium chains |
0 |
0 |
6,13 |
We evaluated:
The impact on brain DHA of a dietary Dairy fat matrix
versus a Palm matrix having the same level of ALA
(1.5%) (figure
1).
The 1.5% ALA dairy fat blend induced similar levels of brain DHA
of young rats, irrespective of the gender, and were significantly
higher to the brain DHA of the young rats on the 1.5% ALA Palm
matrix. Moreover, contrarily to the dairy fat diet, the palm matrix
induced a gender difference, with male rats showing lower levels of
Brain.
The impact on brain DHA of a dietary Dairy fat blend (1.5%
ALA) versus a Palm blend (1.5% ALA)
supplemented with Dietary preformed DHA (0.12%)
(figure
1).
Another diet was tested: 1.5%-ALA palm diet supplemented with
0.12% DHA and 0.4% ARA, to mimic the LC PUFA supplemented formula
and was compared to 1.5% ALA-palm-blend and to 1.5% ALA-dairy-fat
blend, non-supplemented with LCn-3.
The supplementation with dietary preformed DHA to the palm oil
based diet increased the DHA levels in male brains only, and
allowed the restoration of their brain DHA content to the values
found in females brains fed the same1.5% ALA palm diet.
In males and females rats fed with 1.5% ALA dairy fat, the
levels of brain DHA were similar and significantly higher than the
corresponding levels obtained with the 1.5% ALA Palm matrix
supplemented or not with preformed DHA.
Discussion
The main finding of our study is that an anhydrous
dairy-fat-based diet with 1.5% ALA is more efficient than a palm
oil blend providing the same ALA level and 0.12% added DHA and 0.4%
ARA for increasing brain DHA levels in post-weaning rats. Together,
these observations clearly demonstrated that brain DHA levels can
be improved by dairy fat based-diets.
We were unable to show that the various diets cause any
selective desaturase and elongase gene activation (Du et
al., 2011; Tu et al., 2010). Thus, the substrate
quantity and quality impact is probably the mechanism driving the
desaturation pathways toward very LC-PUFA tissue accretion as
observed by others. In that respect, the dairy fats differed from
the plant oils in their content of short- and medium-chain fatty
acids. ALA is one of the best beta-oxidation substrates (Jones,
1994), whose activity can prevent its conversion into very
long-chain-PUFA. Short-chain fatty acids, such as those found in
dairy fats, are also highly oxidized after absorption (Rolland
et al., 2002; Bendixen et al., 2002), may thereby
spare ALA from oxidation, and favor ALA partitioning towards the
desaturation and elongation pathways. The possible sparing of ALA
from beta-oxidation by short-chain fatty acids could be one
of the plausible explanation for our observation that better
bioconversion of ALA into DHA is obtained with the dairy fat blend
compared to the corresponding palm oil blend. Both have as much as
ALA (1.5%) with the same n-6/n-3 ratio. However, this needs to be
precisely addressed and deserves careful examination.
Nonetheless, as observed by others (Childs et al., 2008;
Childs et al., 2010a; Extier et al., 2010), changes
in tissue fatty acid levels due to both dietary and gender
influences occurred even in the brain (Du et al., 2011).
Likewise, we found that the dairy fat-based diets attenuated the
gender influence to a greater extent than the palm-oil-based diets.
The brain DHA levels were lower in males than in females in
palm-oil-based diet but comparable in males and females in the
counterpart diet that provided preformed DHA.
In conclusion, our study shows that a dairy fat blend providing
the recommended values of essential fatty acids (1.5% ALA) with a
LA/ALA ratio of 10 is superior to the plant oil blend even when the
recommended DHA levels are exogenously provided. A gender effect
with regard to brain DHA (lower in males) is linked specifically to
the dietary conditions of the vegetable formula with the
recommended 1.5% levels of ALA, which could be overcome by the DHA
supplementation. Dairy fat should be reevaluated for infant
formulas.
References
Alessandri JM, Goustard B, Guesnet P, Durand G. Polyunsaturated
fatty acids status in blood, heart, liver, intestine, retina and
brain of newborn piglets fed either sow milk or a milk replacer
diet. Reprod Nutr Dev 1996; 36: 95-109.
Bach AC, Babayan VK Medium-chain triglycerides: an update. Am
J Clin Nutr 1982; 36: 950-62.
Bendixen H, Flint A, Raben A, et al. Effect of 3 modified
fats and a conventional fat on appetite, energy intake, energy
expenditure, and substrate oxidation in healthy men. Am J Clin
Nutr 2002; 75: 47-56.
Bowen RA, Clandinin MT. Maternal dietary 22: 6n-3 is more
effective than 18: 3n-3 in increasing the 22: 6n-3 content in
phospholipids of glial cells from neonatal rat brain. Br J
Nutr 2005; 93: 601-11.
Childs CE, Romeu-Nadal M, Burdge GC, Calder PC. Gender
differences in the n-3 fatty acid content of tissues. Proc Nutr
Soc 2008; 67: 19-27.
Childs CE, Romeu-Nadal M, Burdge GC, Calder PC. The
polyunsaturated fatty acid, composition of hepatic and plasma
lipids differ by both sex and dietary fat intake in rats. J
Nutr 2010a; 140: 245-50.
Childs CE, Romijn T, Enke U, Hoile S, Calder PC. Maternal diet
during pregnancy has tissue-specific effects upon fetal fatty acid
composition and alters fetal immune parameters. Prostaglandins
Leukot Essent Fatty Acids 2010b; 83: 179-84.
Childs CE, Fear AL, Hoile SP, Calder PC. Different dietary
omega-3 sources during pregnancy and DHA in the developing rat
brain. OCL 2011; 18: 259-62.
Dabadie H, Peuchant E, Bernard M, LeRuyet P, Mendy F. Moderate
intake of myristic acid in sn-2 position has beneficial lipidic
effects and enhances DHA of cholesteryl esters in an interventional
study. J Nutr Biochem 2005; 16: 375-82.
Extier A, Langelier B, Perruchot MH, et al. Gender
affects liver desaturase expression in a rat model of n-3 fatty
acid repletion. J Nutr Biochem 2010; 21: 180-7.
Directive. 2006/141/CE de la commission, du 22 décembre 2006
concernant les préparations pour nourrissons et les préparations de
suite et modifiant la directive 1999/21/CE, Règlement (CE) n̊
1243/2008 de la commission du 12 décembre 2008.
Guesnet P, Alessandri JM. Docosahexaenoic acid (DHA) and the
developing central nervous system (CNS) - Implications for dietary
recommendations. Biochimie 2011; 93: 7-12.
Hoffman DR, Birch EE, Birch DG, et al. Impact of early
dietary intake and blood lipid composition of long-chain
polyunsaturated fatty acids on later visual development. J
Pediatr Gastroenterol Nutr 2000; 31: 540-53.
Innis SM, Gilley J, Werker J. Are human milk long-chain
polyunsaturated fatty acids related to visual and neural
development in breast-fed term infants? J Pediatr 2001; 139:
532-8.
Innis SM. Dietary (n-3) fatty acids and brain development. J
Nutr 2007; 137: 855-9.
Jones PJ. Dietary linoleic, alpha-linolenic and oleic acids are
oxidized at similar rates in rats fed a diet containing these acids
in equal proportions. Lipids 1994; 29: 491-5.
Legrand P, Beauchamp E, Catheline D, Pedrono F, Rioux V: Short
chain saturated fatty acids decrease circulating cholesterol and
increase tissue PUFA content in the rat. Lipids 2010; 45:
975-86.
Mohrhauer H, Holman RT. The Effect of Dose Level of Essential
Fatty Acids Upon Fatty Acid Composition of the Rat Liver. J
Lipid Res 1963; 4: 151-9.
Plourde M, Cunnane SC. Extremely limited synthesis of long chain
polyunsaturates in adults: implications for their dietary
essentiality and use as supplements. Appl Physiol Nutr Metab
2007; 32: 619-34.
Poumes-Ballihaut C, Langelier B, Houlier F, et al.
Comparative bioavailability of dietary alpha-linolenic and
docosahexaenoic acids in the growing rat. Lipids 2001; 36:
793-800.
Qin Du, Jean-Charles Martin, Genevieve Agnani, et al.
Dairy fat blends high in α-linolenic acid are superior to n-3 fatty
acid-enriched palm oil blends for increasing DHA levels in the
brains of young rats. J Nutr Biochem accepted 2011.
Radbill S, Infant feeding through the ages. Clinical
Pediatrics 1981; 10: 613-21.
Rioux V, Pédrono F, Legrand P. Regulation of mammalian
desaturases by myristic acid: N-terminal myristoylation and other
modulations. Biochim Biophys Acta 2011; 1811: 1-8.
Rolland V, Roseau S, Fromentin G, Nicolaidis S, Tome D, Even PC.
Body weight, body composition, and energy metabolism in lean and
obese Zucker rats fed soybean oil or butter. Am J Clin Nutr
2002; 75: 21-30.
Simopoulos AP. Omega-3 fatty acids in health and disease and in
growth and development. Am J Clin Nutr 1991; 54: 438-63.
Stevens EE, Patrick TE, Pickler R. A history of infant feeding.
J Perinat Educ 2009 Spring; 18:32-39.
Tu WC, Cook-Johnson RJ, James MJ, Muhlhausler BS, Gibson RA.
Omega-3 long chain fatty acid synthesis is regulated more by
substrate levels than gene expression. Prostaglandins Leukot
Essent Fatty Acids 2010; 83: 61-8.
Valenzuela A, Von Bernhardi R, Valenzuela V, et al.
Supplementation of female rats with alpha-linolenic acid or
docosahexaenoic acid leads to the same omega-6/omega-3 LC-PUFA
accretion in mother tissues and in fetal and newborn brains. Ann
Nutr Metab 2004; 48: 28-35.
|